Families and patients can participate in research through KIF1A.ORG , which hosts research networks, clinical study opportunities, and annual conferences to connect with experts. Let me know, and I can provide more targeted details. KIF1A-Associated Neurological Disorder (KAND)
Research is ongoing to understand the different mutations and their effects. A significant study at Boston Children's Hospital is analyzing EEG data to study KAND-associated epilepsy. Kand E01mp4
KAND (KIF1A-Associated Neurological Disorder) is a rare, progressive neurodegenerative disorder caused by mutations in the KIF1A gene. It is characterized by a wide spectrum of severity, often affecting motor function, vision, and cognitive development. Families and patients can participate in research through
Common manifestations include intellectual disability, developmental delays, speech delays, hypotonia (decreased muscle tone), hyperreflexia (exaggerated reflexes), spastic paraplegia (weak/tight leg muscles), optic nerve atrophy (vision loss), peripheral neuropathy, and epilepsy. A significant study at Boston Children's Hospital is